Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 42291-774

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 42291-774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 (773 60 500mg)

The label for AvKARE Ranolazine Extended-Release Tablets shows the 500 mg strength in film-coated, extended-release oral tablet form. The package contains 60 tablets with instructions not to crush, break, or chew. Storage instructions and manufacturer information (AvKARE, TN) are also included, along with NDC and barcode details.*

FDA Label Image

1000 (774 60 1000mg)

Label for Ranolazine Extended-Release Tablets 1000 mg by AvKARE. The oral film-coated tablet package contains 60 tablets. Instructions note to swallow whole without crushing, breaking, or chewing. The label includes storage instructions and a barcode.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of ranolazine, showing its molecular configuration with aromatic rings, nitrogen atoms, hydroxyl group, and methoxy group as part of its structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.